The USTEKID trial is studying whether Ustekinumab can help extend the honeymoon period in adolescents (12-18y old) with newly diagnosed Type 1 Diabetes

ID: 970245393622630400

linkhttps://www.type1diabetesresearch.org.uk/current-trials/ustekid/ calendar_today04-03-2018 10:31:42